Resources

This good practice case study focuses on the One Recovery Bucks drugs service BBV pathway. Implementation of the pathway has seen the proportion of patients who test positive for hepatitis C going on to access treatment increase from 18% to over 90%.

This December 2019 update to the Shooting Up: Infections among people who inject drugs in the UK, produced by Public Health England, provides updated data to the end of 2018. The report says that there is early evidence for a reduction in chronic hepatitis C prevalence among injecting drug users, but that rates of new infection are unchanged, including amongst individuals who have recently started injecting.

Presentations from speakers at the HCV Action good practice roadshow held in Woking on November 28th 2019 focusing on best practice in testing and treating people with hepatitis C in prisons. Presentations covered good practice from around England as well as a national overview on the hepatitis C elimination deal from the National Lead for Public Health in secure and detained settings.

This good practice case study looks at the service developed in a collaboration between Courts Pharmacy in Ramsgate, a nurse from East Kent Hospitals University NHS Foundation Trust, and The Forward Trust. Patients who are deemed unlikely to independently manage four weeks of treatment are given the medication in the pharmacy itself so they do not have to look after large numbers of tablets for long periods of time, getting around current legislative barriers preventing the dispensing of hepatitis C treatment from pharmacies.